PRS:同期行环臂抽脂和手臂轮廓术安全可靠效果好

2021-04-20 MedSci原创 MedSci原创

改善手臂的美学轮廓而不切除多余的皮肤是一项巨大的挑战。这项研究报告了在同一手术期进行环臂抽脂和手臂轮廓术。它提供了详细的技术结果,包括患者满意度,旨在根据艾尔·卡提布分类评估其在治疗2B

改善手臂的美学轮廓而不切除多余的皮肤是一项巨大的挑战。这项研究报告了在同一手术期进行环臂抽脂和手臂轮廓术。它提供了详细的技术结果,包括患者满意度,旨在根据艾尔·卡提布分类评估其在治疗2B级和3级手臂脂肪代谢障碍中的有效性和安全性。

手臂轮廓手术可以分为三组,分别是处理皮肤冗余、处理脂肪代谢障碍以及两者兼而有之的。这项研究试图找到一个关于同时环臂抽脂和手臂轮廓术安全性的争论的答案。

62例患者(女49例,男13例)接受同期环臂抽脂和手臂轮廓术。从术后至少6个月开始评估术前和术后的臂围,以及术后并发症和患者满意度。

图1所示。(上图,左)术前左臂和外侧胸壁标记(前视图)。(上图右)术前左臂和侧胸壁标记(后视图)。(中间)左臂环周抽脂术后术中视图显示皮肤厚度。(下,左)完成周向抽脂后,伤口在抽吸管上层层闭合。(右下)吸出的液体、脂肪和组织的数量

图2。(左上)左臂前视图,皮肤下垂和3期脂肪过多。术前中臂周长41.2 cm。(上图,右图)左臂术前后视图。(下图,左)术后一年,左臂前视图,未见疤痕。臂围31.5 cm。(下图,右图)左臂术后1年的后视图,看不到疤痕。

表1 .患者人口统计、并发症、手术数据和满意度

结果显示,只有2名患者(3.2%)出现小面积伤口裂开,在反复包扎和延长加压衣物使用时间后愈合。

1名患者(1.6%)出现增生性瘢痕,采用局部压迫和硅胶片治疗。中臂周径减少5~14 cm,平均9 cm。

在这项研究中,大约95.2%的患者非常满意,4.8%的患者报告说略有满意。

根据这项研究的结果,环臂抽脂并手臂轮廓术是一种安全、有效、可靠和可行的手术。它既可以减少过多的脂肪,也可以改善手臂皮肤下垂。环臂抽脂和手臂轮廓术也不会增加并发症的发生率。结果令患者非常满意。

原始文献:

Ahmad Mahfouz S I,Circumferential Lipobrachioplasty Is a Safe Procedure.[J] .Plast Reconstr Surg, 2021, 147: 337-344.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1709139, encodeId=90631e0913973, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Mar 31 04:21:14 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669067, encodeId=fd46166906eba, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Nov 14 11:21:14 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958963, encodeId=8ac895896397, content=学习了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Wed Apr 21 07:05:57 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047327, encodeId=a4dd104e327dd, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 02:21:14 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958929, encodeId=a03095892991, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Apr 20 23:26:23 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2022-03-31 zywlvao
  2. [GetPortalCommentsPageByObjectIdResponse(id=1709139, encodeId=90631e0913973, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Mar 31 04:21:14 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669067, encodeId=fd46166906eba, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Nov 14 11:21:14 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958963, encodeId=8ac895896397, content=学习了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Wed Apr 21 07:05:57 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047327, encodeId=a4dd104e327dd, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 02:21:14 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958929, encodeId=a03095892991, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Apr 20 23:26:23 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-11-14 kzlchina
  3. [GetPortalCommentsPageByObjectIdResponse(id=1709139, encodeId=90631e0913973, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Mar 31 04:21:14 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669067, encodeId=fd46166906eba, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Nov 14 11:21:14 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958963, encodeId=8ac895896397, content=学习了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Wed Apr 21 07:05:57 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047327, encodeId=a4dd104e327dd, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 02:21:14 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958929, encodeId=a03095892991, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Apr 20 23:26:23 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-04-21 学医无涯

    学习了~

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1709139, encodeId=90631e0913973, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Mar 31 04:21:14 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669067, encodeId=fd46166906eba, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Nov 14 11:21:14 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958963, encodeId=8ac895896397, content=学习了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Wed Apr 21 07:05:57 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047327, encodeId=a4dd104e327dd, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 02:21:14 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958929, encodeId=a03095892991, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Apr 20 23:26:23 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-04-21 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1709139, encodeId=90631e0913973, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Mar 31 04:21:14 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669067, encodeId=fd46166906eba, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Nov 14 11:21:14 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958963, encodeId=8ac895896397, content=学习了~, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Wed Apr 21 07:05:57 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047327, encodeId=a4dd104e327dd, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 02:21:14 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958929, encodeId=a03095892991, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Apr 20 23:26:23 CST 2021, time=2021-04-20, status=1, ipAttribution=)]
    2021-04-20 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

Br J Surg:CSAL治疗腿部淋巴水肿

腿部的晚期淋巴水肿的治疗是具有挑战性的,尤其是当保守治疗失败,受影响和不受影响腿之间的体积差异变得更大时。四周负压抽脂术(CSAL)已被描述为终末期淋巴水肿腿的治疗选择。在这里,分析CSAL治疗终末期原发性和继发性淋巴水肿腿的长期结果。这是一项关于CSAL治疗单侧慢性不可逆的淋巴水肿的描述性研究。术后恢复压迫疗法。手术前测量腿体积,并在术后1、6、12和24个月后测量腿体积。47例原发性淋巴水肿患

拓展阅读

是认真的吗?抽脂后成了这副鬼模样,还瞎了……

今天我们学习一例罕见的腹部和大腿抽脂术后单侧失明和多发性皮肤坏死的病例,该手术采用清创术和植皮治疗。

Aesthetic Plast Surg:通过抽脂术重建乳房下皱褶:重建乳房美学必要技术

乳房下皱褶(IMF)是乳房重要的美学组成部分,它限制了乳房的下缘,并决定了乳房下垂的程度,本文描述了患者在不同的乳房手术(主要是乳房切除后重建)中重建和确定IMF的技术,并介绍了所取得的长期结果。

10 年回顾性研究:多阶段吸脂术后患者报告的脂肪水肿相关症状改善

尽管外科手术治疗脂肪水肿的需求越来越大,但抽脂术的证据仍然有限。关于疾病分期、患者年龄、体重指数或现有共病对临床结果的影响知之甚少。

多中心研究显示,这项TULUA腹部抽脂术效果美观,安全又可靠!

TULUA(横向折叠,无破坏性,完全吸脂,新脐成形术和腹部下横向瘢痕)是一种完全不同的腹部脂肪成形术的首字母缩写,旨在增加简单性,提高血管安全性,并获得良好效果。

快速安全又有效,不用抽脂也能拥有六块腹肌的午间整形术式!

虽说腹部抽脂可以增强肌肉轮廓,但抽脂是有创术式,本文分享了一种无创溶脂术式,并评估了这种术式的安全性和有效性。

JAAD:连续3430例不同浓度利多卡因肿胀局麻吸脂效果观察

抽脂术是全世界最常见的整形外科手术之一。肿胀局部麻醉(TLA)技术的引入使手术过程发生了革命性的变化,使用400 mg/L的利多卡因生理盐水对大部分身体区域提供足够的麻醉.

2022 BAAPS/BAPRAS建议:抽脂术治疗脂肪水肿

英国美容整形外科医师协会(BAAPS,British association of aesthetic plastic surgeons) · 2022-12-21